共 113 条
[11]
DiNardo CD(2019)Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Blood 133 7-17
[12]
Rau RE(2016)DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia Blood 128 971-981
[13]
Cucchi DGJ(2021)Two decades of targeted therapies in acute myeloid leukemia Leukemia 35 651-660
[14]
Ghandi M(2019)Next-generation characterization of the Cancer Cell Line Encyclopedia Nature 569 503-508
[15]
Dai YJ(2017)Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement Proc. Natl Acad. Sci. USA 114 5237-5242
[16]
Cavallaro U(2004)Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat. Rev. Cancer 4 118-132
[17]
Christofori G(2014)Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin Stem Cells 32 926-937
[18]
Malara A(2003)Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia Nat. Med 9 1158-1165
[19]
Matsunaga T(2020)Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance Nat. Commun. 11 303-320
[20]
Barbier V(2019)Haematopoietic stem cell activity and interactions with the niche Nat. Rev. Mol. Cell Biol. 20 e1704463-3019